Stefano Codognotto

Stefano Codognotto is a Regulatory Affairs professional with extensive experience in Development and Quality Assurance, particularly within biologics and Advanced Therapy Medicinal Products (ATMP). They have contributed significantly to clinical trial development and drug strategy, overseeing processes from early phases to post-marketing. Having held positions at esteemed organizations including PPD and Parexel, Stefano specializes in strategic regulatory development and consulting, with interests spanning rare diseases, gene therapies, and quality assurance. They earned their degree from Università degli Studi di Ferrara and have managed quality assurance at notable institutions such as King's College London and the Royal Free London NHS Foundation Trust.